MEG3 and central nervous system cancer: In the MEG3 silenced glioma group, 25% of the cells were engaged in a cell death process (p = 0.0036) while only 0.5% and 2% of control and MEG3 overexpressing cells were, respectively, undergoing cell death (Figure 6B).